Inogen Q2 revenue $95.1M (+3% YoY); raises FY adjusted EBITDA guidance to ~$4.0M

Inogen Inc

Q2 revenue $95.1M (+3% YoY); international revenue $41.3M (+14.8% YoY).
GAAP net loss $3.9M vs $4.2M loss prior year; adjusted EBITDA positive $2.4M vs $2.1M.
Raised FY 2026 adjusted EBITDA guidance to ~$4.0M (up 48% from 2025); revenue guidance $355M-$361M.
Cash $106.8M, no debt; repurchased 1.15M shares for $7.5M in H1 2026.
Launched Rove 6 in Canada; completed Simeox H study enrollment in China; added Andy Reding as COO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.